The present review aims to summarize the most recent evidence related to imaging and severe asthma, both with regard to advances in imaging research and to their current and potential clinical implications.
INTRODUCTION
Asthma comprises a broad range of patient phenotypes, classically characterized by recurrent episodes of airway obstruction and reversible airflow limitation, usually in the setting of chronic airway inflammation and bronchial hyper-responsiveness [1, 2] . The term 'severe asthma' does not relate to a specific pathobiological entity or even a specific phenotype, but rather occurs in those patients who are unable to maintain control of their disease, never attain control of their disease, or who require treatment with high dose inhaled or systemic corticosteroids as well as a second controller medication [1, 3] . Although this group represents only 5-10% of asthmatics as a whole, they account for nearly 50% of the healthcare costs related to asthma, thus any strategies that can improve the diagnosis and management of these patients may have a significant impact both on their quality of life and on the economic burden of the disease [1] . Over the past several decades many investigators have shown that multiple imaging modalities can be used to reliably differentiate those with severe asthma from those with milder disease, and increasingly there is discussion of what role imaging may play in both diagnosing and monitoring severe asthmatics. As there have been multiple prior reviews of this literature, in this review, we briefly discuss both older, but important, imaging studies of asthmatics, and place particular emphasis on recent advances in the imaging of severe asthmatics [4] [5] [6] [7] [8] .
CHEST RADIOGRAPHY
The role of chest radiography in chronic management of asthma has been discussed multiple times elsewhere and there have been few recent advances in this area [7] . However, it is worth noting that chest radiography continues to play an important role in the management of patients with severe asthma in the acute setting, such as during an admission for asthma exacerbation. In a small study of 58 patients admitted for asthma exacerbations, White et al. [9] reported major radiograph abnormalities in 34% and minor abnormalities in an additional 41%. Of these findings, pneumothorax and pneumomediastinum are by far the most concerning. The rate of pneumothorax in patients admitted for status asthmaticus has been reported as somewhere between 0.5 and 2.5%, but in at least one series, it was the immediate cause of death in 27% of those who died from their asthma exacerbation [10, 11] . Although there is some debate about the sensitivity of chest radiography for pneumothoraces, it remains a highly effective screening tool for large pneumothoraces, and when performed in the left lateral decubitus position, is up to 88% sensitive for pneumothorax under experimental conditions [12] .
COMPUTED TOMOGRAPHY
Clinically, the role of computed tomography (CT) imaging in asthma is primarily related to the diagnosis of complications and associated conditions. As mentioned above, pneumothorax is a rare but severe complication of severe asthma, which primarily occurs in the setting of status asthmaticus [10, 11] . Chest CT is generally considered the gold standard for diagnosing pneumothorax and is especially useful in severe asthmatics with an acute decompensation, or whenever the clinical setting suggests the possibility of a pneumothorax, such as in the setting of high airway pressures on mechanical ventilation [10, 13, 14] . CT scanning may also be useful for diagnosing diseases associated with asthma, such as allergic bronchopulmonary aspergillosis, eosinophilic pneumonia, and eosinophilic granulomatosis with polyangiitis [7] .
Much of the work on the CT radiographic correlates of pathologic findings in severe asthma was detailed in the excellent review on the subject in this journal by Walker et al. in 2012 [6] . Qualitative studies of CT scans performed on severe asthmatics have shown relatively high rates of bronchiectasis and bronchial wall thickening [6, 15] . These findings have been associated with worse lung function and longer disease duration, but these associations have not been uniform across studies, and whether these findings reflect an underlying pathobiological cause of disease severity or whether they are simply natural manifestations of disease progression is unclear [6, [15] [16] [17] [18] [19] [20] [21] [22] .
More recently, there has been a growing focus on quantitative CT measures of disease severity in asthma. Similar to the qualitative assessment of chest radiographs, the main findings of interest on CT scans of asthmatics, especially severe asthmatics, can be broken down into those that relate to morphologic changes in the larger airways, and those that suggest small airway dysfunction, manifested primarily as regional variation of hyperinflation. With regard to the quantitative analysis of the larger airways in particular, much of the work has focused on CT measurements of the airway wall thickness, wall area, and lumen area. For instance, Aysola et al. [23] performed automated measurements of third generation airways in 123 subjects as part of the National Institutes of Health Severe Asthma Research Program. They found that although airway wall thickness was not higher in severe asthmatics when compared to those with mild asthma or no disease, wall thickness percentage (wall thickness divided by outer airway diameter) was higher in those with severe asthma. Wall thickness percentage was also inversely correlated with baseline percentage predicted forced expiratory volume in one second (FEV1%) and positively correlated with change in FEV1% with bronchodilator challenge. They found similar results for the airway wall area percentage (airway wall area divided by the total area of the airway), and for the airway lumen area percentage (airway lumen area divided by the total area of the airway) [23] . In a subgroup of subjects who underwent endobronchial biopsies, Aysola et al. [23] found that the wall area percentage also correlated with the ratio of epithelium to lamina reticularis area, suggesting
KEY POINTS
Clinically, traditional chest radiography and computed tomography (CT) continue to play a key role in the diagnosis of complications from severe asthma, such as pneumothoraces and bronchiectasis.
Quantitative analysis of CT images has shown that both measures of airway thickening and measures of gas trapping are associated with impairments of lung function, and further advances in dual energy xenon enhanced CT imaging may improve regional measurements of gas trapping in particular.
MRI that utilizes hyperpolarized gas has revealed associations between ventilation defects in patients with asthma and both CT measurements of airway remodeling as well as lung function impairment.
The functional nature of hyperpolarized MRI measurements suggests that, combined with quantitative CT analysis, it may provide useful information to both guide and quantify the asthmatics' therapy, but further work is needed before its integration into routine clinical care.
that the findings on CT represented radiographic evidence of airway remodeling (Fig. 1) . Others, including Hartley et al. [24] , have recently shown that in asthmatics wall area percentage in particular is one of the strongest predictors of lung function impairment. Another interesting quantitative CT measure, described by Brillet et al. [25] in a small series of patients with severe asthma, is focal airway stenoses measured as a greater than 50% decrease of the lumen area. The authors found that severe asthmatics had more focal bronchial stenoses than those without asthma and suggested that this may be the result of airways remodeling and increased basal tone [25] . Further studies might shed light on the clinical potential of this measure.
It should be noted that, as pointed out by Walker et al., findings related to clinical associations with CT-based airway measurements in asthma have not been uniform across the literature and may be subject to inter-center variability in patient population and imaging analysis protocols [6, 26, 27] . In fact, it is not clear even which, if any, generation of airway best demonstrates these changes. For example, Thomson et al. [28] found an association between the airway lumen area of fifth-generation airways and poor symptom control among smokers with asthma, but they did not find any such relationship with third-generation airways, nor was it evident in a study of nonsmoking asthmatics by Kaminska et al. [29] . Finally, the density of the airway wall itself has also been shown by Lederlin et al. [30] to be higher in asthmatics than in normal controls, and may be more strongly correlated with lung function than the aforementioned geometric airway measures.
Although the size of the small airways places them below the level of resolution of CT scanning, the results of asthma's effect on these airways can be visualized as air trapping. Air trapping can be objectively measured as changes in density on CT [6, 31, 32] . This can be quantified in a variety of ways, but is most commonly reported in absolute terms on either inspiratory or expiratory CT scans as the volume of tissue with a density below a certain Hounsfield unit cutoff or as the ratio or difference between the mean lung density on expiratory CT scan and inspiratory CT scan [6, [33] [34] [35] [36] . For instance, Gupta et al. [36] showed that patients with severe asthma have greater air trapping measured as an expiratory to inspiratory density ratio than those with mild disease and those without asthma. Interestingly, by combining these density measures with the geometric airway measures discussed above, as well as with a measure of the complexity of the tracheobronchial tree, Gupta et al. [36] were able to identify three novel asthma phenotypes with distinct clinical and radiographic features. The use of these techniques to begin to identify unique patient groups suggests that CT imaging may be useful for identifying those individuals who may benefit from certain therapies in the future, especially as others have begun to evaluate the role of CT imaging in monitoring response to therapy [37] .
Finally, although whole lung measures of air trapping are useful, asthma is often characterized by regional variations in ventilation because of small airways disease. Through the use of xenon enhanced CT this regional variation can be assessed more directly than with standard CT imaging, but until recently this technique was limited by technical issues relating to the changes in lung volume between scans [38, 39] . The development of dual energy xenon enhanced CT imaging has overcome that problem [38, 40] . In their report on their initial experience with this technique Chae et al. [40] showed that a ventilation defect score in stable asthmatics correlated with residual lung volume and with the forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ratio. Kim et al. [38] demonstrated that this score was different between asthmatics and normal controls both at baseline and after methacholine challenge. Further research is needed to best determine the role of this imaging technique in the assessment of asthmatics and in severe asthmatics in particular.
MAGNETIC RESONANCE IMAGING
Although primarily limited to the research setting, MRI has been demonstrated to have several potential advantages for the imaging of patients with severe asthma. Chief among those is its ability to provide images that depict the regional distribution of ventilation defects in asthma across the entire lung [8] . This is particularly true of MRI that utilizes hyperpolarized gas, typically either hyperpolarized helium ( 3 He) or xenon ( 129 Xe). Quantified measures of these ventilation defects have been shown to be associated with lower FEV1/FVC ratio, and higher methacholine responsiveness and expired nitric oxide levels in adults as well as with higher inhaled corticosteroid dose, and lower FEV1/FVC ratio and asthma control test scores in children [41 & ,42] . The primary clinical limitation of this technique, especially in those with severe disease, is that the respectively. Reproduced by permission from [48] .
Asthma inhaled gas, which in the case of the more commonly utilized 3 He method is a helium-nitrogen mixture, is anoxic and displaces air from the lungs. This results in desaturations during the breath hold maneuver, although typically not less than 90% [8, 43] . Ongoing work on oxygen enhanced MRI imaging may ameliorate that problem [44] . An additional concern is that the breath hold maneuver is often long, up to 20 s, which may not be feasible for patients with more severe asthma.
There are several other limitations to the use of hyperpolarized MRI imaging in particular, including the need for specialized gas mixtures that are only approved for investigational use, and the inability to clearly identify anatomic structures [8, 45] . This had led to the use of co-registration of hyperpolarized MRI images with standard MRI images or with CT images as well as investigation into the use of other approaches to standard MRI imaging which may be able to provide similar information [42,45,46,47 & ]. This work has led to several fascinating findings, including the association between MRI measured ventilation defects and CT measurements of airway remodeling as well as the presence of both intermittent and persistent ventilation defects in patients with asthma [42, 48] . Interestingly the percentage of the lung comprised of both the intermittent ventilation defects and persistent defects is inversely associated with FEV1/FVC ratio (Fig. 2 ) [48] . In addition to improving our overall understanding of the disease, the ability of MRI to measure regional variation in ventilation may be particularly useful for severe asthmatics for whom bronchial thermoplasty is considered [49 & ]. For instance, in a small study, Thomen et al. [49 & ] quantified lung ventilation in bronchopulmonary segments in severe asthmatics. They found that compared to controls, those with severe asthma have 2.3 times higher median ventilation defect percentage and that ventilation defects decrease over time after bronchial thermoplasty [49 & ]. These findings suggest that imaging might be helpful to guide and quantify response to therapy.
CONCLUSION
Multiple imaging modalities including chest radiography, CT, and MRI have been shown to be useful in the evaluation of patients with severe asthma. Clinically, these approaches are most commonly used for the evaluation for complications such as pneumothoraces, but many of the more research focused techniques, especially quantitative measures of airway morphology, may soon find their way into larger clinical practice as experience with them grows and the ability to perform automated measurements improves. Further work evaluating such clinical use, as well as multicenter studies investigating the role of using these measures longitudinally to monitor disease progression and response to therapy, is needed.
